Transgenic animal whose expression of the opiate receptors is modified
US6632977B2 · kind B2 · utility
1Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 1999 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Jun 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0356
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention concerns the use of a non-human transgenic mammal whose expression of a gene coding for an opiate receptor is modified, particularly in the nerve tissues with respect to a normal expression, in particular in the nerve tissues, for producing a medicine for the treatment of pathological conditions involving opiate receptors, in particular severe acute or chronic pains, drug addiction or the prevention or the treatment of transplant rejections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.